Immunity and Vaccine Development for Neisseria meningitidis

Immunity and Vaccine Development for Neisseria meningitidis

Assessment

Passage

Science

12th Grade

Hard

Created by

Adam Ewing

FREE Resource

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the case-fatality rate of untreated Neisseria meningitidis cases?

Near 100%

5% to 15%

50% to 70%

10%

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which serogroups of Neisseria meningitidis are most common in developed countries?

B, C, Y, W135

A, B, C, Y

A, C, Y, W135

B, C, W135, X

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Why is the polysaccharide capsule of serogroup B poorly immunogenic?

Similarity to human brain and fetal antigens

Lack of immune memory

High mutation rate

Low antibody affinity

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the efficacy range of outer membrane vesicle (OMV) vaccines in trials?

51% to 80%

30% to 50%

70% to 90%

40% to 60%

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What cytokine response is skewed in young children after meningococcal infection?

TH1 response

TH2 response

TH17 response

Treg response